1/ There are various tweets misinterpreting COVID-19 “pre-existing immunity” and making dangerous claims about herd immunity. Since many of those claims refer to our scientific papers, we will reiterate the facts. @SetteLab @ljiresearch @ScienceMagazine @CellCellPress
2/ Our 1st scientific paper showed that ~50% of unexposed people have T cells that recognized SARS-CoV-2 already doi.org/10.1016/j.cell…. The most obvious conclusion was these were memory T cells from previous common cold coronavirus infections, but that was not directly shown.
3/ Our 2nd paper, very recently published, showed that these were memory T cells from previous common cold coronavirus infections doi.org/10.1126/scienc…. Five other labs have also published related findings doi.org/10.1038/s41577…
4/ These observations about pre-existing T cell immunity (also call "crossreactive immune memory", which avoids the word "immunity" that sometimes gets misinterpreted as “protective immunity” [sorry, immunology is complicated] ) are important because...
5/ ...these memory cells MAY impact people’s responses to SARS-CoV-2 infection, or COVID-19 vaccines.
6/ Therefore, we have pointed out that these coronavirus crossreactive immune memory T cells are important to pay attention to in human COVID-19 studies this year.
7/ We SPECULATE that it is conceivable that these T cells may potentially reduce COVID-19 disease severity, based on things we know about flu and T cells.
8/ These are only speculations (no data) and because of their potential importance it is key for scientists to test these ideas, as quickly as possible. While scientists are racing as fast as possible, sophisticated research like this usually takes a lot of time and resources.
9/ We, and other labs, are working hard on these unanswered questions.
10/ Additionally, even if our most optimistic speculations about crossreactive T cell memory were found to be correct, it would mean that just as many people would get infected with SARS-CoV-2, but fewer would become severely ill and die from COVID-19.
11/ T cells generally don’t completely prevent infections, they limit disease (make it shorter and/or less serious). Thus, wearing a mask is much more effective than hoping you and the people around you have pre-existing T cell memory. Wearing a mask stops infections.
12/ For people who were asking for more information about masks, extensive data support that masks are one of the most effective interventions to reduce SARS-CoV-2 spread and COVID-19 cases:
13/ One excellent new summary of the scientific and medical literature is: link.springer.com/article/10.100… .

Or if you prefer one study: thelancet.com/journals/lance…

Or if you prefer 70 sources: threader.app/thread/1279144…
14/ But if you prefer a visual aid summarizing the knowledge on masks and COVID-19, National Geographic @NatGeo has you covered: nationalgeographic.com/science/2020/0…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Prof. Shane Crotty

Prof. Shane Crotty Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @profshanecrotty

24 Sep
CDC Director Dr. Walensky made the right decision last night on boosters. 🧵
Boosters now available (not required) for Pfizer vaxxed after 6 months:
🔵  65 and older
🔵  healthcare workers
🔵  nursing home residents
🔵  50 and older with health problems
apnews.com/article/corona…
This was in line with the FDA decision last week. It also matches my suggestions two weeks ago on TWIV and VOSD. And earlier on UCSF Grand Rounds. It makes sense to have vaccine boosters available to these people, who received the Pfizer vaccine.
Again, the Pfizer vaccine booster shot is *available*. It is not *required* to count as fully vaxxed. That is because without the booster shot, the vaccine is still doing an outstanding job at preventing serious COVID-19.
Read 21 tweets
20 Sep
Good news! Pfizer data today indicate they have a safe and effective COVID-19 vaccine for kids ages 5 to 11. Kids vaxxed by Halloween? 🧵
🔵  Antibody titers as high as adults
🔵  "Favorable safety profile" with 10 microgram dose used
🔵  Filing with FDA

pfizer.com/news/press-rel…
🔵  Antibody titers were as high as adults

The fact that the peak antibody titers are equal between the kids 5 to 11 years old and young adults indicates the COVID vaccine will be protective in the kids.
🔵  "Favorable safety profile" with the 10 microgram dose used

Pfizer used a dose of 10 in the kids instead if the 30 used in adults. That was a reasonable decision, and they see fewer side effects with the lower kid dose (fevers, chills, etc). Other doses were tested early on.
Read 10 tweets
20 Sep
Good news! Pfizer data today indicate they have a safe and effective COVID-19 vaccine for kids ages 5 to 11. Kids vexed by Halloween? 🧵
🔵  Antibody titers as high as adults
🔵  "Favorable safety profile" with 10 microgram dose used
🔵  Filing with FDA.

pfizer.com/news/press-rel…
🔵  Antibody titers were as high as adults

The fact that the peak antibody titers are equal between the kids 5 to 11 years old and young adults indicates the COVID vaccine will be protective in the kids.
🔵  "Favorable safety profile" with the 10 microgram dose used

Pfizer used a dose of 10 in the kids instead if the 30 used in adults. That was a reasonable decision, and they see fewer side effects with the lower kid dose (fevers, chills, etc). Other doses were tested early on.
Read 10 tweets
14 Sep
Our newest study is out in Science!
It cover 5 COVID-19 RNA vaccine topics. Using samples from the "low dose" 25mcg Moderna RNA COVID-19 vaccine clinical trial 🧵👇🏼
science.org/doi/10.1126/sc…
By the LJI team! @Dani6020 @SetteLab @jmateust @ljiresearch
The five finding summarized here:
🔵  T cell memory to an RNA vaccine at 7 months
🔵  Vaccine dose sparing (25mcg v 100mcg)
🔵  Vaccine v. natural immunity
🔵  T cell memory with age
🔵  Pre-existing crossreactive memory T cells: Do they do anything?
🔵  T cell memory to an RNA vaccine:

Impressive T cell memory at 7 months (6 months after 2nd dose). CD4s & CD8s. Tfh & cytokine+.

Overall, looks like two doses of an RNA vaccine generates impressive T cell memory that is likely to last for many years.
Even 25mcg Moderna dose
Read 12 tweets
31 Aug
Just a friendly reminder that this study also addressed natural immunity compared to vaccine immunity. Vaccine immunity did somewhat better than natural immunity, including against Delta. Image
In that large, carefully done, prospective, longitudinal study in the UK of over 300,000 people with regular testing, both vaccine immunity and natural immunity showed significant protection against COVID-19, with vaccine immunity doing somewhat better than natural immunity. ImageImage
As a prospective study, with a randomization component, the conclusions have higher confidence compared to some other studies. including against Delta.
Read 4 tweets
21 Aug
Boosters+global equity:
Practically speaking, the US should continue to retain enough doses to vaccinate all unvaccinated Americans. But resistance to vaccination remains high, so there is probably little to no real cost in allowing Americans who want boosters to get a 3rd dose
The USA has to keep trying hard to vaccinate the unvaccinated. But many of those reserved doses will likely expire otherwise, sadly.

Discussed some in the chat with @CarlosdelRio7 @Bob_Wachter at the end
Any vaccine dose given to an unvaccinated American is FAR more valuable than a 3rd dose given to a vaccinated American. For preventing deaths, hospitalizations, cases, and transmissions.
washingtonpost.com/outlook/corona…
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(